GR3034757T3 - Compositons for the treatment of chronic fatigue syndrome. - Google Patents

Compositons for the treatment of chronic fatigue syndrome.

Info

Publication number
GR3034757T3
GR3034757T3 GR20000402446T GR20000402446T GR3034757T3 GR 3034757 T3 GR3034757 T3 GR 3034757T3 GR 20000402446 T GR20000402446 T GR 20000402446T GR 20000402446 T GR20000402446 T GR 20000402446T GR 3034757 T3 GR3034757 T3 GR 3034757T3
Authority
GR
Greece
Prior art keywords
compositons
treatment
chronic fatigue
fatigue syndrome
syndrome
Prior art date
Application number
GR20000402446T
Other languages
English (en)
Inventor
Thomas Peter Bridge
Frederick K Goodwin
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Publication of GR3034757T3 publication Critical patent/GR3034757T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GR20000402446T 1991-05-08 2000-11-07 Compositons for the treatment of chronic fatigue syndrome. GR3034757T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/696,556 US5189022A (en) 1988-05-27 1991-05-08 Composition for the treatment of chronic fatigue syndrome
PCT/US1992/003582 WO1992019257A1 (en) 1991-05-08 1992-05-08 Compositons for the treatment of chronic fatigue syndrome

Publications (1)

Publication Number Publication Date
GR3034757T3 true GR3034757T3 (en) 2001-02-28

Family

ID=24797555

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000402446T GR3034757T3 (en) 1991-05-08 2000-11-07 Compositons for the treatment of chronic fatigue syndrome.

Country Status (10)

Country Link
US (1) US5189022A (el)
EP (1) EP0584247B1 (el)
JP (1) JP3215110B2 (el)
AU (1) AU663875B2 (el)
CA (1) CA2102606C (el)
DE (1) DE69231384T2 (el)
DK (1) DK0584247T3 (el)
ES (1) ES2149177T3 (el)
GR (1) GR3034757T3 (el)
WO (1) WO1992019257A1 (el)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5739109A (en) * 1988-12-16 1998-04-14 Advanced Immunit Inc. Method of treating neuroinflammatory degenerative diseases
JPH05262654A (ja) * 1992-03-18 1993-10-12 Kaken Pharmaceut Co Ltd 慢性疲労症候群治療剤
US6011014A (en) * 1992-03-27 2000-01-04 Advanced Immunit, Inc. Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis
ATE267838T1 (de) * 1992-03-27 2004-06-15 Advanced Immuni T Inc T-peptid und damit verwandte peptide in der behandlung von entzündungen einschlies slich der multiplen sklerose
JP3499562B2 (ja) * 1993-09-24 2004-02-23 アドヴァンスト・イミューニット・インク Ｃｒｏｈｎ’ｓ病および／または潰瘍性大腸炎の治療もしくは予防
DE69433763T2 (de) * 1993-09-24 2005-04-14 Advanced Immuni T, Inc. Lineare und cyklische peptide zur behandlung oder verhinderung von ekzem und dermatitis
US5712259A (en) * 1996-04-22 1998-01-27 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome
US6537997B1 (en) 1997-02-18 2003-03-25 A. Martin Lerner Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
US6399622B1 (en) 1997-02-18 2002-06-04 A. Martin Lerner Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
US5872123A (en) * 1997-02-18 1999-02-16 Lerner; A. Martin Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
EP1909815A4 (en) * 2005-07-26 2011-05-18 Cms Peptides Patent Holding Company Ltd NEW BIOLOGICALLY ACTIVE PEPTIDES AND THEIR NEW USES
US20140100238A1 (en) 2012-10-04 2014-04-10 Ohio State University Method of diagnosing and treating epstein barr virus-based myalgic encephalomyelitis chronic fatigue syndrome patients

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880626A (en) * 1985-01-18 1989-11-14 Mcmichael John Immunotherapeutic methods and compositions for the treatment of diseases of viral origin, including acquired immune deficiency syndrome
US5013739A (en) * 1986-10-07 1991-05-07 Bernard Bihari Method of treating chronic fatigue syndrome using an opiate receptor antagonist
EP0415999B1 (en) * 1988-05-27 1998-07-22 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Compositions having use as treatment of psoriasis and neuropsychiatric deficits
US5063206A (en) * 1988-12-16 1991-11-05 The United States Of Americas As Represented By The Department Of Health And Human Services Compositions having use as treatment of neuropsychiatric deficits

Also Published As

Publication number Publication date
CA2102606A1 (en) 1992-11-09
AU663875B2 (en) 1995-10-26
AU2015292A (en) 1992-12-21
DK0584247T3 (da) 2000-11-06
JP3215110B2 (ja) 2001-10-02
EP0584247A1 (en) 1994-03-02
CA2102606C (en) 2003-02-11
WO1992019257A1 (en) 1992-11-12
EP0584247B1 (en) 2000-08-23
EP0584247A4 (en) 1994-09-14
DE69231384D1 (de) 2000-09-28
JPH06510749A (ja) 1994-12-01
ES2149177T3 (es) 2000-11-01
DE69231384T2 (de) 2001-02-01
US5189022A (en) 1993-02-23

Similar Documents

Publication Publication Date Title
DE69206378D1 (de) Patientenliegetische.
EP0590350A3 (en) Noise control device.
ITTO920145A0 (it) Valvola multifunzionale per paziente.
EP0572208A3 (en) Noise control device.
ZA927562B (en) Medicament.
PH31380A (en) Medicaments for treating inflammatory conditions or for analgesia.
DE59401899D1 (de) Längenverstellbare Säule für Stühle, Tische o.dgl.
GR3034757T3 (en) Compositons for the treatment of chronic fatigue syndrome.
GR3022569T3 (en) The treatment of meat.
DE69327812D1 (de) Arsen-enthaltende arzneimittel zur behandlung des chronischen ermüdungssyndroms
GR3023328T3 (en) Structureborne noise isolator.
EP0649308A4 (en) PREVENTION OF HEMOLYSIS.
FR2679878B1 (fr) Plateaux de palettisation.
DE59205402D1 (de) Längenverstellbare Säule für Tische, Stühle od.dgl.
EP0609335A4 (en) Methods for the treatment of hyperlipidemia using azaspiranes.
EP0620992A3 (de) Möbel.
GB9107569D0 (en) Wood treatment
AU5160193A (en) Arsenic medicaments for the treatment of the chronic asthenia syndrome
ZA923505B (en) Treatment of fatigue syndrome
CS361891A3 (en) vaccine for treating chronic elytronitis
GB9220110D0 (en) Treatment ofsepsis syndrome
EP0589132A3 (de) Winkelverstellbare Möbelkombination.
PH31066A (en) Treatment composition.
FR2677632B1 (fr) Leve-dalles.
EP0979653A4 (en) MEDICINE AGAINST CHRONIC FATIGUE SYNDROME

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees